Hong Kong stock abnormal movement | Poze Pharmaceuticals-B (02589.HK) up nearly 5% against the market trend. The company's drug Shinowa was previously approved for listing, and has now submitted KJ017 NDA.

- According to the Zhito Finance APP, Baodi Pharmaceutical - B (02589.HK) rose nearly 5% against the market trend. As of the time of reporting, it has risen by 3.79% to 68.45 Hong Kong dollars, with a turnover of 18.3776 million Hong Kong dollars.